AMRX Earnings

Quarterly EPS
$-0.10
Q4 2024
$0.04
Q1 2025
$0.07
Q2 2025
$0.01
Q3 2025
$0.11
Q4 2025
$0.20
Q1 2026
$0.18
Q2 2026
$-0.06
Q3 2026
Latest Revenue862.7M
Latest Net Income12.3M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$0.06862.7M12.3M+10.0%-700.0%
Q2 2026$0.18796.2M69.6M+9.9%+157.1%
Q1 2026$0.20722.5M78.0M+3.9%+400.0%
Q4 2025$0.11814.3M49.6M+11.5%+210.0%
Q3 2025$0.01784.5M18.1M+11.7%—
Q2 2025$0.07724.5M35.6M+3.2%+250.0%
Q1 2025$0.04695.4M24.6M+5.5%+113.3%
Q4 2024-$0.10730.5M-20742000+18.4%+75.0%
Q3 2024$0.00702.5M11.8M——
Q2 2024$0.02701.8M16.8M——
Q1 2024-$0.30659.2M-81678000——
Q4 2023-$0.40617.0M-93344000——
Amneal Pharmaceuticals (AMRX) — Earnings